Published in Int J Obes Relat Metab Disord on October 01, 1999
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66
Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations. Int J Obes (Lond) (2008) 1.03
The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obes Rev (2015) 0.88
Relationship between plasma leptin levels and lipid profiles among school children in Taiwan--the Taipei Children Heart Study. Eur J Epidemiol (2001) 0.88
The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol (2013) 0.88
Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells. Stem Cells (2015) 0.85
Serum leptin level is reduced in non-obese subjects with type 2 diabetes. Int J Endocrinol Metab (2012) 0.85
Leptin levels in obese women with and without type 2 diabetes mellitus. Mediators Inflamm (2004) 0.83
The leptin gene family and colorectal cancer: interaction with smoking behavior and family history of cancer. PLoS One (2013) 0.83
Excessive Leucine-mTORC1-Signalling of Cow Milk-Based Infant Formula: The Missing Link to Understand Early Childhood Obesity. J Obes (2012) 0.83
Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells. Cancer Prev Res (Phila) (2015) 0.82
Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells. Reprod Biol Endocrinol (2009) 0.82
Change of Body Composition and Adipokines and Their Relationship with Insulin Resistance across Pubertal Development in Obese and Nonobese Chinese Children: The BCAMS Study. Int J Endocrinol (2012) 0.81
Association of inflammatory sialoproteins, lipid peroxides and serum magnesium levels with cardiometabolic risk factors in obese children of South Indian population. Int J Biomed Sci (2014) 0.81
Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) (2012) 0.81
GATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cells. J Cell Mol Med (2016) 0.75
Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart J (2016) 0.75
Association of Leptin with Body Pain in Women. J Womens Health (Larchmt) (2016) 0.75
Leptin levels and nutritional status of indigenous Tepehuán and Mestizo subjects in Durango, Mexico. Dis Markers (2014) 0.75
Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes. Ci Ji Yi Xue Za Zhi (2017) 0.75
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med (1984) 1.90
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ (1994) 1.47
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) (2006) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
Proteinuria in diabetes. Diabetologia (1983) 1.07
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes (2000) 1.07
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology (1995) 1.06
Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord (1998) 1.06
Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 1.04
Microalbuminuria as prediction of nephropathy in diabetics. Lancet (1982) 1.02
Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia (1995) 1.00
Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord (2000) 0.98
Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care (2000) 0.97
Ursodeoxycholic acid in chronic liver disease. Gut (1991) 0.97
Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes (2000) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Intracaval and intracardiac leiomyomatosis of uterine origin. Ann Vasc Surg (1986) 0.95
The A19G polymorphism in the 5' untranslated region of the human obese gene does not affect leptin levels in severely obese patients. J Clin Endocrinol Metab (2000) 0.94
Dietary composition and renal function in healthy subjects. Nephron (1987) 0.94
Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) (1981) 0.93
Memory impairment in Cushing's disease. Acta Neurol Scand (1993) 0.93
Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord (2002) 0.92
Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int (1994) 0.92
Diabetic nephropathy. Br Med Bull (1989) 0.91
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. Diabetes Care (2000) 0.91
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes (1996) 0.91
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. J Lipid Res (2001) 0.90
Glucocorticoids and neuroendocrine function. Int J Obes Relat Metab Disord (2000) 0.89
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther (2006) 0.89
Contribution of weight cycling to serum leptin in human obesity. Int J Obes Relat Metab Disord (2001) 0.89
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord (1998) 0.88
Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med (1983) 0.87
The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron (2002) 0.87
Weight cycling and cardiovascular risk factors in obesity. Int J Obes Relat Metab Disord (2004) 0.87
Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant (1999) 0.87
Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol (1995) 0.86
Review: low caloric intake and gall-bladder motor function. Aliment Pharmacol Ther (2000) 0.86
Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol (Oxf) (1984) 0.86
Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia (2008) 0.86
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Early functional and morphological changes in diabetic nephropathy. Clin Nephrol (1979) 0.85
Use of ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab (1986) 0.85
Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron (1984) 0.84
Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia (1993) 0.84
Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant (1997) 0.84
Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care (1987) 0.84
P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia (2003) 0.84
Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial. Ital J Gastroenterol (1993) 0.84
Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. Kidney Int (1998) 0.83
Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes (1988) 0.83
Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration. Diabetes (1982) 0.83
Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci (1989) 0.83
Predictors of postabsorptive ghrelin secretion after intake of different macronutrients. J Clin Endocrinol Metab (2006) 0.83
Rationale for hospital-based rehabilitation in obesity with comorbidities. Eur J Phys Rehabil Med (2013) 0.83
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. Metabolism (1980) 0.82
Glucose-induced hyperkalaemia: A hazard for diabetics? Lancet (1978) 0.81
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes (2000) 0.81
Changes in renal function in response to protein restricted diet in type 1 (insulin-dependent) diabetic patients. Diabetologia (1987) 0.81
Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia (1996) 0.81
Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest (2003) 0.81